CoviDx™ SARS-CoV-2 Rapid Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal (NS) swabs and nasopharyngeal (NP) swabs from patients suspected of a Coronavirus-19 (COVID-19) infection by their healthcare provider within the first 5 days of symptoms.
- Results in 15 minutes.
- CoviDx allows for optimal disease management and immediate patient isolation
- Pre-filled extraction vials and individually wrapped swabs enable multiple independent workstations for increased test distribution
- Facilitates professionally administered testing at the point of need, such as workplace testing and airport screening
- Room temperature storage
- 25 test kit
The COVIDx-SARS-CoV-2 Rapid Antigen Test Kit is manufactured in the United States by Lumos Diagnostics Inc. and was approved by Health Canada on November 2, 2021.
Buy the COVIDx-SARS-CoV-2 Rapid Antigen Test Kit for Your WorkPlace
If your company or organization is interested in rapid testing solutions, contact us today for help procuring the COVIDx-SARS-CoV-2 Rapid Antigen Test Kit or other rapid tests approved by Health Canada. Our team at Rapid Test & Trace Canada can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
